Literature DB >> 26595072

At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study.

N Martínez-Cibrian1, L Magnano1, G Gutiérrez-García1, X Andrade1, J G Correa1, M Suárez-Lledó1, C Martínez1, M Rovira1, E Carreras1,2, L Rosiñol1, C F de Larrea1, M T Cibeira1, A Gaya1, C Gallego1, A Hernando1, N Creus3, J Bladé1, Á Urbano-Ispizua1,2, F Fernández-Avilés1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26595072     DOI： 10.1038/bmt.2015.287

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Authors:  Thomas J Smith; James Khatcheressian; Gary H Lyman; Howard Ozer; James O Armitage; Lodovico Balducci; Charles L Bennett; Scott B Cantor; Jeffrey Crawford; Scott J Cross; George Demetri; Christopher E Desch; Philip A Pizzo; Charles A Schiffer; Lee Schwartzberg; Mark R Somerfield; George Somlo; James C Wade; James L Wade; Rodger J Winn; Antoinette J Wozniak; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2006-05-08       Impact factor: 44.544

2.  Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma.

Authors:  Fortunato Morabito; Massimo Martino; Caterina Stelitano; Esther Oliva; Mariagrazia Kropp; Giuseppe Irrera; Giuseppe Console; Mohamed Fujo; Giuseppe Messina; Stefano Molica; Vincenzo Callea; Pasquale Iacopino
Journal:  Haematologica       Date:  2002-11       Impact factor: 9.941

3.  Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  M Akasheh; D Eastwood; D H Vesole
Journal:  Bone Marrow Transplant       Date:  2003-01       Impact factor: 5.483

4.  A risk-adapted protocol for delayed administration of filgrastim after high-dose chemotherapy and autologous stem cell transplantation.

Authors:  Amit Khot; Michael Dickinson; Kerrie Stokes; Simon Harrison; Kate Burbury; Shaun Fleming; Dominic Wall; Peter Gambell; H Miles Prince; John F Seymour; David Ritchie
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-11-10

5.  Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies.

Authors:  Francesc Fernández-Avilés; Enric Carreras; Alvaro Urbano-Ispizua; Montserrat Rovira; Carmen Martínez; Anna Gaya; Miquel Granell; Laia Ramiro; Cristina Gallego; Adela Hernando; Susana Segura; Lourdes García; Manel González; Montserrat Valverde; Emili Montserrat
Journal:  J Clin Oncol       Date:  2006-09-25       Impact factor: 44.544

6.  Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma.

Authors:  Andreas Holbro; Imran Ahmad; Sandra Cohen; Jean Roy; Silvy Lachance; Miguel Chagnon; Richard LeBlanc; Lea Bernard; Lambert Busque; Denis Claude Roy; Guy Sauvageau; Thomas L Kiss
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-16       Impact factor: 5.742

7.  Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center.

Authors:  E Carreras; F Fernández-Avilés; L Silva; M Guerrero; C Fernández de Larrea; C Martínez; L Rosiñol; M Lozano; P Marín; M Rovira
Journal:  Bone Marrow Transplant       Date:  2010-01-11       Impact factor: 5.483

Review 8.  Optimal use of G-CSF administration after hematopoietic SCT.

Authors:  M Trivedi; S Martinez; S Corringham; K Medley; E D Ball
Journal:  Bone Marrow Transplant       Date:  2009-04-13       Impact factor: 5.483

Review 9.  Interventions for treating oral mucositis for patients with cancer receiving treatment.

Authors:  J E Clarkson; H V Worthington; O B Eden
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

10.  Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria.

Authors:  A Maiolino; I Biasoli; J Lima; A C Portugal; W Pulcheri; M Nucci
Journal:  Bone Marrow Transplant       Date:  2003-03       Impact factor: 5.483
View more
  2 in total

1.  Personalized at-home autologous hematopoietic stem cell transplantation during the SARS-CoV-2 outbreak.

Authors:  Alexandra Martínez-Roca; Luis Gerardo Rodríguez-Lobato; Nuria Ballestar; Cristina Gallego; Francesc Fernández-Avilés
Journal:  Leuk Res       Date:  2021-04-24       Impact factor: 3.156

2.  The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever.

Authors:  Luis-Gerardo Rodríguez-Lobato; Alexandra Martínez-Roca; Sandra Castaño-Díez; Alicia Palomino-Mosquera; Gonzalo Gutiérrez-García; Alexandra Pedraza; María Suárez-Lledó; Montserrat Rovira; Carmen Martínez; Carlos Fernández de Larrea; María-Teresa Cibeira; Laura Rosiñol; Ester Lozano; Pedro Marín; Joan Cid; Miquel Lozano; Ana Belén Moreno-Castaño; Marta Palomo; Maribel Díaz-Ricart; Cristina Gallego; Adelina Hernando; Susana Segura; Enric Carreras; Álvaro Urbano-Ispizua; Joan Bladé; Francesc Fernández-Avilés
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.